Hsp27: A novel therapeutic target for pediatric M4/M5 acute myeloid leukemia

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1459-1466

  Yang, Liangchun ^a   Cao, Lizhi ^a   Yang, Minghua ^a   Tang, Daolin ^b   Kang, Rui ^a,b   Min, Xie ^a   Zhu, Shan ^a   Yu, Yan ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Chemosensitivity; Heat shock protein 27; M4 M5; Pediatric acute leukemia

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYTARABINE; CYTARABINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; HEAT SHOCK PROTEIN 27; HEMOGLOBIN; HOMOHARRINGTONINE; IDARUBICIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; YITUOBOGAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INDUCTION CHEMOTHERAPY; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; THROMBOCYTE COUNT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE MARROW; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INFANT; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MOLECULAR TARGETED THERAPY; RNA, SMALL INTERFERING;

EID: 84874718501     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2274     Document Type: Article

References (37)

1. Woods WG: Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep. Pediatr Blood Cancer 46: 565-569, 2006.
2. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J and Lehrnbecher T: Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM93 and AML-BFM 98. J Clin Oncol 22: 4384-4393, 2004.
3. Pui CH, Carroll WL, Meshinchi S and Arceci RJ: Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 29: 551-565, 2011.
4. Rubnitz JE and Inaba H: Childhood acute myeloid leukemia. Br J Haematol 159: 259-276, 2012.
5. Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C and Gleave M: Increased Hsp27 after androgen ablation facili-tates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res 65: 11083-11093, 2005.
6. Love S and King RJ: A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J Cancer 69: 743-748, 1994.
7. Huang Q, Ye J, Chen W, et al: Heat shock protein 27 is overex¬pressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 48: 263-269, 2010.
8. Langdon SP, Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF and Miller WR: Expression of the heat shock protein Hsp27 in human ovarian cancer. Clin Cancer Res 1: 1603-1609, 1995.
9. Lebret T, Watson RW, Molinié V, O'Neill A, Gabriel C, Fitzpatrick JM and Botto H: Heat shock proteins Hsp27, Hsp60, Hsp70, and Hsp90: expression in bladder carcinoma. Cancer 98: 970-977, 2003.
10. Melle C, Ernst G, Escher N, et al: Protein profiling of micro¬dissected pancreas carcinoma and identification of Hsp27 as a potential serum marker. Clin Chem 53: 629-635, 2007.
11. Yu Z, Zhi J, Peng X, Zhong X and Xu A: Clinical significance of Hsp27 expression in colorectal cancer. Mol Med Rep 3: 953-958, 2010.
12. Tweedle EM, Khattak I, Ang CW, et al: Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut 59: 1501-1510, 2010.
13. Wang F, Zhang P, Shi C, Yang Y and Qin H: Immunohistochemical detection of Hsp27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer. Med Oncol 29: 1780-1788, 2012.
14. Yang YX, Xiao ZQ, Chen ZC, et al: Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 6: 2009-2021, 2006.
15. Andrieu C, Taieb D, Baylot V, et al: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene 29: 1883-1896, 2010.
16. Havasi A, Li Z, Wang Z, et al: Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 283: 12305-12313, 2008.
17. O'Callaghan-Sunol C, Gabai VL and Sherman MY: Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 67: 11779-11788, 2007.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625, 1985.
19. Cheson BD, Cassileth PA, Head DR, et al: Report of the National Cancer Institute sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia: review. J Clin Oncol 8: 813-819, 1990.
20. Yang L, Yu Y, Kang R, et al: Up-regulated autophagy by endog¬enous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma 53: 315-322, 2012.
21. Yang L, Yang M, Zhang H, et al: S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by downregulating autophagy. Int J Mol Med 29: 65-72, 2012.
22. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B and Mehlen P: Hsp27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 57: 2661-2267, 1997.
23. Williams K, Chubb C, Huberman E and Giometti CS: Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 19: 333-343, 1998.
24. Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I and Lubec G: Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2: 8, 2004.
25. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL and Fuqua SA: Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 85: 1558 1570, 1993.
26. Chen GY and Nuñez G: Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2010.
27. Kaspers GJ and Creutzig U: Pediatric acute myeloid leukemia: international progress and future directions. Leukemia 19: 2025 2029, 2005.
28. Molgaard-Hansen L, Glosli H, Jahnukainen K, et al: Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO-AML study. Pediatr Blood Cancer 57: 1222-1229, 2011.
29. Jo A, Tsukimoto I, Ishii E, Asou N, et al: Age-associated differ¬ence in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correla¬tion with prognosis. Br J Haematol 144: 917-929, 2009.
30. Ravindranath Y, Chang M, Steuber CP, et al: Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19: 2101-2116, 2005.
31. Estey E and Dohner H: Acute myeloid leukaemia. Lancet 368: 1894-1907, 2006.
32. Dutcher JP, Schiffer CA and Wiernik PH: Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 5: 1364-1372, 1987.
33. Ross DD: Novel mechanisms of drug resistance in leukemia. Leukemia 14: 467-473, 2000.
34. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, et al: Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
35. Choi DH, Ha JS, Lee WH, et al: Heat shock protein 27 is associ¬ated with irinotecan resistance in human colorectal cancer cells. FEBS Lett 581: 1649-1656, 2007.
36. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M and Garrido C: Heat shock proteins: essential proteins for apoptosis regulation. J Cel Mol Med 12: 743-761, 2008.
37. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB and Doseff AI: Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 282: 25088-25099, 2007.